Roger Gammon, MD
Roger S. Gammon, M.D. is the Medical Director of Research & Interventional Cardiologist with Austin Heart has been the principal investigator of more than 50 trials and sub-investigator of 20 clinical trials. He received an undergraduate degree from University of Missouri, Kansas City, Missouri completed his internship and residency at University of Texas Health Science Center and served as a visiting chief resident at Massachusetts General Hospital at Harvard Medical School. He completed his Interventional Cardiology Fellowship at Duke University Medical Center, Durham, NC. Dr. Gammon’s stem cell research is focused on adult stem cell applications in patients after Acute Myocardial Infarction (MI) and in patients with Critical Limb Ischemia (CLI) due to Peripheral Vascular Disease. The results from a Phase I trial for which he was a lead PI were published in the Journal of the American College of Cardiology and reported that patients were treated safely with intravenous adult human mesenchymal stem after a heart attack. In addition, these patients had fewer arrhythmias, improved heart and lung function, and improvement in overall condition. He is a now principal investigator conducting the Phase II, Multi-center study evaluating the safety and efficacy of adult human mesenchymal stem cells for acute myocardial infarction. Austin Heart is currently participating in a trial using the patient’s own stem cells to potentially save their leg from amputation when interventions and surgery are not possible.